Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-18-022403
Filing Date
2018-04-25
Accepted
2018-04-25 16:31:49
Documents
5
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tv491338_10ka.htm 10-K/A 196175
2 EXHIBIT 10.28 tv491338_ex10-28.htm EX-10.28 7210
3 EXHIBIT 10.29 tv491338_ex10-29.htm EX-10.29 6469
4 EXHIBIT 31.1 tv491338_ex31-1.htm EX-31.1 3510
5 EXHIBIT 31.2 tv491338_ex31-2.htm EX-31.2 3818
  Complete submission text file 0001144204-18-022403.txt   218506
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36435 | Film No.: 18774746
SIC: 2836 Biological Products, (No Diagnostic Substances)